MedPath
NMPA Approval

Rivaroxaban Tablets

国药准字H20258041

March 25, 2025

国药准字H20233402

Drug Information

利伐沙班片

片剂

15mg

化学药品

March 25, 2025

Company Information

Applicant Company

江苏省苏州吴中经济开发区民丰路268号

Manufacturing Company

江苏省苏州吴中经济开发区民丰路268号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利伐沙班片 - NMPA 批准文号 | MedPath